Varghese, Abraham M <br/><br/>
Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia.  [electronic resource] 

 -  British journal of haematology  09 2018 
 - 927-930 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.14884  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--pharmacology<br/>Calcium Signaling--drug effects<br/>Cell Survival--drug effects<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Phosphorylation--drug effects<br/>Pyrimidines--pharmacology<br/>Syk Kinase--antagonists & inhibitors<br/>Tumor Cells, Cultured